Agile Therapeutics Announces Participation at Upcoming Investor Conferences
17 11월 2015 - 9:45PM
Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty
pharmaceutical company focused on the development and
commercialization of new prescription contraceptive products, today
announced that Al Altomari, President and Chief Executive Officer,
will participate in the following investor conferences during the
month of December:
- 27th Annual Piper Jaffray Healthcare
Conference New York, NY December 2, 2015
Fireside Chat will be held at 11:50 AM ET and will be webcast
live on the internet. To access the webcast, please visit the
Investors Relations section of the Company's website at
www.agiletherapeutics.com.
- 2015 RBC Capital Market’s Healthcare Investor
DayDenver, CODecember 10, 2015
About Agile Therapeutics,
Inc.
Agile Therapeutics is a women's health specialty
pharmaceutical company focused on the development and
commercialization of new prescription contraceptive products. Our
product candidates are designed to provide women with contraceptive
options that offer greater convenience and facilitate compliance.
Our lead product candidate, Twirla®, (ethinyl estradiol and
levonorgestrel transdermal system), also known as AG200-15, is a
once-weekly prescription contraceptive patch currently in Phase 3
clinical development. Twirla is based on our proprietary
transdermal patch technology, called Skinfusion®, which is designed
to provide advantages over currently available patches and is
intended to optimize patch adherence and patient acceptability. For
more information, please visit the company website at
www.agiletherapeutics.com. The company may occasionally disseminate
material, nonpublic information on the company website.
Contact: Mary Coleman -- 609-356-1921
Agile Therapeutics (NASDAQ:AGRX)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Agile Therapeutics (NASDAQ:AGRX)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024